Amarin Corporation PLC (AMRN) Reports First Quarter 2012 Financial Results and Provides Update on Operations  
5/9/2012 10:18:27 AM

BEDMINSTER, N.J., and DUBLIN, Ireland, May 8, 2012 (GLOBE NEWSWIRE) -- Amarin Corporation plc (Nasdaq:AMRN), a late-stage biopharmaceutical company focused on cardiovascular disease, today announced financial results for the quarter ended March 31, 2012 and provided an update on company operations.